The Duration of Zidovudine Benefit in Persons With Asymptomatic HIV Infection: Prolonged Evaluation of Protocol 019 of the AIDS Clinical Trials Group

Paul A. Volberding; Stephen W. Lagakos; Janet M. Grimes; Daniel S. Stein; Henry H. Balfour; Richard C. Reichman; John A. Bartlett; Martin S. Hirsch; John P. Phair; Ronald T. Mitsuyasu; Margaret A. Fischl; Ruy Soeiro

doi:10.1001/jama.1994.03520060037029

The Duration of Zidovudine Benefit in Persons With Asymptomatic HIV Infection: Prolonged Evaluation of Protocol 019 of the AIDS Clinical Trials Group

Paul A. Volberding, Stephen W. Lagakos, Janet M. Grimes, Daniel S. Stein, Henry H. Balfour, Richard C. Reichman, John A. Bartlett, Martin S. Hirsch, John P. Phair, Ronald T. Mitsuyasu, Margaret A. Fischl, Ruy Soeiro

Medicine, Infectious Diseases Division

Research output: Contribution to journal › Article › peer-review

126 Scopus citations

Original language	English (US)
Pages (from-to)	437-442
Number of pages	6
Journal	JAMA: The Journal of the American Medical Association
Volume	272
Issue number	6
DOIs	https://doi.org/10.1001/jama.1994.03520060037029
State	Published - Aug 10 1994

ASJC Scopus subject areas

Medicine(all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/jama.1994.03520060037029

Cite this

Volberding, P. A., Lagakos, S. W., Grimes, J. M., Stein, D. S., Balfour, H. H., Reichman, R. C., Bartlett, J. A., Hirsch, M. S., Phair, J. P., Mitsuyasu, R. T., Fischl, M. A., & Soeiro, R. (1994). The Duration of Zidovudine Benefit in Persons With Asymptomatic HIV Infection: Prolonged Evaluation of Protocol 019 of the AIDS Clinical Trials Group. JAMA: The Journal of the American Medical Association, 272(6), 437-442. https://doi.org/10.1001/jama.1994.03520060037029

@article{0541dc496ad04ec1b173b3b078441fc1,

title = "The Duration of Zidovudine Benefit in Persons With Asymptomatic HIV Infection: Prolonged Evaluation of Protocol 019 of the AIDS Clinical Trials Group",

author = "Volberding, {Paul A.} and Lagakos, {Stephen W.} and Grimes, {Janet M.} and Stein, {Daniel S.} and Balfour, {Henry H.} and Reichman, {Richard C.} and Bartlett, {John A.} and Hirsch, {Martin S.} and Phair, {John P.} and Mitsuyasu, {Ronald T.} and Fischl, {Margaret A.} and Ruy Soeiro",

year = "1994",

month = aug,

day = "10",

doi = "10.1001/jama.1994.03520060037029",

language = "English (US)",

volume = "272",

pages = "437--442",

journal = "JAMA: The Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "6",

}

Volberding, PA, Lagakos, SW, Grimes, JM, Stein, DS, Balfour, HH, Reichman, RC, Bartlett, JA, Hirsch, MS, Phair, JP, Mitsuyasu, RT, Fischl, MA & Soeiro, R 1994, 'The Duration of Zidovudine Benefit in Persons With Asymptomatic HIV Infection: Prolonged Evaluation of Protocol 019 of the AIDS Clinical Trials Group', JAMA: The Journal of the American Medical Association, vol. 272, no. 6, pp. 437-442. https://doi.org/10.1001/jama.1994.03520060037029

The Duration of Zidovudine Benefit in Persons With Asymptomatic HIV Infection: Prolonged Evaluation of Protocol 019 of the AIDS Clinical Trials Group. / Volberding, Paul A.; Lagakos, Stephen W.; Grimes, Janet M. et al.
In: JAMA: The Journal of the American Medical Association, Vol. 272, No. 6, 10.08.1994, p. 437-442.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - The Duration of Zidovudine Benefit in Persons With Asymptomatic HIV Infection

T2 - Prolonged Evaluation of Protocol 019 of the AIDS Clinical Trials Group

AU - Volberding, Paul A.

AU - Lagakos, Stephen W.

AU - Grimes, Janet M.

AU - Stein, Daniel S.

AU - Balfour, Henry H.

AU - Reichman, Richard C.

AU - Bartlett, John A.

AU - Hirsch, Martin S.

AU - Phair, John P.

AU - Mitsuyasu, Ronald T.

AU - Fischl, Margaret A.

AU - Soeiro, Ruy

PY - 1994/8/10

Y1 - 1994/8/10

UR - http://www.scopus.com/inward/record.url?scp=0028049465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028049465&partnerID=8YFLogxK

U2 - 10.1001/jama.1994.03520060037029

DO - 10.1001/jama.1994.03520060037029

M3 - Article

C2 - 7913730

AN - SCOPUS:0028049465

SN - 0098-7484

VL - 272

SP - 437

EP - 442

JO - JAMA: The Journal of the American Medical Association

JF - JAMA: The Journal of the American Medical Association

IS - 6

ER -

The Duration of Zidovudine Benefit in Persons With Asymptomatic HIV Infection: Prolonged Evaluation of Protocol 019 of the AIDS Clinical Trials Group

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this